AR and prostate neoplasm: ADT alone can only block the production of androgens from the testis but cannot inhibit the secretion of androgens and their derivatives from the pituitary adrenal axis, nor can it block androgens produced by prostate tumor cells; however, ADT combined with novel androgen receptor antagonists can block androgens from multiple sources to a greater extent.